These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29029419)

  • 1. CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4.
    Li W; Qian L; Lin J; Huang G; Hao N; Wei X; Wang W; Liang J
    Oncotarget; 2017 Sep; 8(39):65143-65151. PubMed ID: 29029419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.
    Li W; Cohen A; Sun Y; Squires J; Braas D; Graeber TG; Du L; Li G; Li Z; Xu X; Chen X; Huang J
    Mol Cancer Res; 2016 Apr; 14(4):344-53. PubMed ID: 26832214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
    Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
    Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.
    Park YS; Huh JW; Lee JH; Kim HR
    Oncol Rep; 2012 Feb; 27(2):339-46. PubMed ID: 22076607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
    Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
    Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells.
    Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
    J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
    Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
    FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
    Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
    Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
    Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
    Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells.
    Lee SY; Kim KA; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2017 Jan; 50(1):329-336. PubMed ID: 27959393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
    Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
    Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.
    Sasaki H; Klotz LH; Sugar LM; Kiss A; Venkateswaran V
    Biochem Biophys Res Commun; 2015 Aug; 464(3):848-54. PubMed ID: 26182875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
    Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-κB signaling.
    Erdogan S; Doganlar O; Doganlar ZB; Serttas R; Turkekul K; Dibirdik I; Bilir A
    Life Sci; 2016 Oct; 162():77-86. PubMed ID: 27569589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells.
    Nam K; Oh S; Lee KM; Yoo SA; Shin I
    Cell Signal; 2015 Sep; 27(9):1882-94. PubMed ID: 25979842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction.
    Chen C; Zhang Q; Liu S; Parajuli KR; Qu Y; Mei J; Chen Z; Zhang H; Khismatullin DB; You Z
    Prostate; 2015 Jun; 75(8):883-95. PubMed ID: 25683512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.